An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study

Authors:
  • APAlan Pestronk
    Alan Pestronk
  • WDWilliam David
    William David
  • JRJeffrey Rothstein
    Jeffrey Rothstein
  • ESEricka Simpson
    Ericka Simpson
  • SAStanley H Appel
    Stanley H Appel
  • PAPatricia L Andres
    Patricia L Andres
  • KMKaty Mahoney
    Katy Mahoney
  • PAPeggy Allred
    Peggy Allred
  • KAKatie Alexander
    Katie Alexander
  • DSDavid Schoenfeld
    David Schoenfeld

Abstract
No abstract available
Funding Information
  • ALS Association
  • Muscular Dystrophy Association
  • National Institutes of Health (K08NS074194, R01NS078398)
  • National Center for Advancing Translational Sciences
  • Institute of Clinical and Translational Sciences (UL1 TR000448)
  • National Institute of Neurological Disorders and Stroke

This publication has 22 references indexed in Scilit: